Cargando…
MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy
AIMS: Inflammation of the heart is a complex biological and pathophysiological response of the immune system to a variety of injuries leading to tissue damage and heart failure. MicroRNAs (miRNAs) emerge as pivotal players in the development of numerous diseases, suggesting their potential utility a...
Autores principales: | Aleshcheva, Ganna, Baumeier, Christian, Harms, Dominik, Bock, C.‐Thomas, Escher, Felicitas, Schultheiss, Heinz‐Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682862/ https://www.ncbi.nlm.nih.gov/pubmed/37679968 http://dx.doi.org/10.1002/ehf2.14523 |
Ejemplares similares
-
MicroRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies
por: Aleshcheva, Ganna, et al.
Publicado: (2020) -
Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy
por: Baumeier, Christian, et al.
Publicado: (2021) -
Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches
por: Baumeier, Christian, et al.
Publicado: (2023) -
Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2022) -
Viral Myocarditis—From Pathophysiology to Treatment
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2021)